• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含磺酸盐的硫杂环丙烷作为选择性明胶酶抑制剂。

Sulfonate-containing thiiranes as selective gelatinase inhibitors.

作者信息

Testero Sebastian A, Lee Mijoon, Staran Rachel T, Espahbodi Mana, Llarrull Leticia I, Toth Marta, Mobashery Shahriar, Chang Mayland

机构信息

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

出版信息

ACS Med Chem Lett. 2010 Dec 13;2(2):177-81. doi: 10.1021/ml100254e. eCollection 2011 Feb 10.

DOI:10.1021/ml100254e
PMID:24900296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4018095/
Abstract

Matrix metalloproteinases (MMPs) are important zinc-dependent endopeptidases. Two members of this family of enzymes called gelatinases (MMP-2 and MMP-9) have been implicated in a number of human diseases, including cancer, neurological and cardiovascular diseases, and inflammation, to name a few. We describe in this report the preparation and evaluation of two structural types of thiirane inhibitors that show selectivity toward gelatinases. The biphenyl series targets both gelatinases, whereas the monophenyl analogues exhibit potent inhibition of only MMP-2. The latter structural type also exhibits improved water solubility and metabolic stability, both traits desirable for progress of these molecules forward in gelatinase-dependent animal models of disease.

摘要

基质金属蛋白酶(MMPs)是一类重要的锌依赖性内肽酶。该酶家族中的两个成员,即明胶酶(MMP - 2和MMP - 9),与多种人类疾病有关,如癌症、神经和心血管疾病以及炎症等。在本报告中,我们描述了两种对明胶酶具有选择性的硫杂环丙烷抑制剂的制备和评估。联苯系列对两种明胶酶都有作用,而单苯基类似物仅对MMP - 2有强效抑制作用。后一种结构类型还表现出改善的水溶性和代谢稳定性,这两个特性对于这些分子在依赖明胶酶的疾病动物模型中的进一步研究是有利的。

相似文献

1
Sulfonate-containing thiiranes as selective gelatinase inhibitors.含磺酸盐的硫杂环丙烷作为选择性明胶酶抑制剂。
ACS Med Chem Lett. 2010 Dec 13;2(2):177-81. doi: 10.1021/ml100254e. eCollection 2011 Feb 10.
2
Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.作为潜在的明胶酶和 MT1-MMP 抑制剂,(±)-2-(1-(4-苯氧基苯磺酰基)乙基)硫代吗啉的立体选择性合成、动力学特征和代谢研究。
Chem Biol Drug Des. 2009 Dec;74(6):535-46. doi: 10.1111/j.1747-0285.2009.00898.x. Epub 2009 Oct 12.
3
Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.设计和合成选择性和血脑屏障穿透性的基于羟肟酸的明胶酶抑制剂。
Bioorg Chem. 2020 Jan;94:103365. doi: 10.1016/j.bioorg.2019.103365. Epub 2019 Oct 18.
4
Potent mechanism-based inhibitors for matrix metalloproteinases.基于机制的强效基质金属蛋白酶抑制剂。
J Biol Chem. 2005 Oct 7;280(40):33992-4002. doi: 10.1074/jbc.M504303200. Epub 2005 Jul 26.
5
Exploring the functional space of thiiranes as gelatinase inhibitors using click chemistry.利用点击化学探索硫杂环丙烷作为明胶酶抑制剂的功能空间。
ARKIVOC. 2011;2011(7):221-226. doi: 10.3998/ark.5550190.0012.719. Epub 2011 Feb 27.
6
Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.噬菌体展示技术分离的功能模拟肽通过选择性地与纤维连接蛋白结构域相互作用,抑制明胶酶。
J Cell Biochem. 2019 Dec;120(12):19699-19711. doi: 10.1002/jcb.29276. Epub 2019 Jul 3.
7
N-substituted homopiperazine barbiturates as gelatinase inhibitors.N-取代的同哌嗪类巴比妥酸盐作为明胶酶抑制剂。
Bioorg Med Chem. 2011 Aug 15;19(16):4985-99. doi: 10.1016/j.bmc.2011.06.055. Epub 2011 Jun 25.
8
In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.计算机模拟支架评估和固相方法鉴定新型明胶酶抑制剂。
Bioorg Med Chem. 2012 Apr 1;20(7):2323-37. doi: 10.1016/j.bmc.2012.02.010. Epub 2012 Feb 13.
9
Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.对明胶酶具有选择性的强效慢结合抑制剂的设计、合成与表征。
J Biol Chem. 2002 Mar 29;277(13):11201-7. doi: 10.1074/jbc.M111021200. Epub 2002 Jan 14.
10
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).人基质金属蛋白酶-2(MMP-2)强效慢结合抑制的结构基础
J Biol Chem. 2003 Jul 18;278(29):27009-15. doi: 10.1074/jbc.M301139200. Epub 2003 Apr 4.

引用本文的文献

1
Epoxides: Small Rings to Play with under Asymmetric Organocatalysis.环氧化合物:不对称有机催化作用下可用于研究的小环化合物
ACS Org Inorg Au. 2022 Aug 3;2(4):289-305. doi: 10.1021/acsorginorgau.2c00009. Epub 2022 Mar 29.
2
Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.揭开大脑细胞外基质及其蛋白水解重塑的神秘面纱:结构与功能的新视角。
Cell Mol Life Sci. 2019 Aug;76(16):3229-3248. doi: 10.1007/s00018-019-03182-6. Epub 2019 Jun 13.
3
Targeting MMP-9 in Diabetic Foot Ulcers.针对糖尿病足溃疡中的基质金属蛋白酶-9
Pharmaceuticals (Basel). 2019 May 22;12(2):79. doi: 10.3390/ph12020079.
4
Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.从一个聚焦合成文库中发现人胰腺羧肽酶A的基于机制的失活剂
ACS Med Chem Lett. 2017 Sep 22;8(10):1122-1127. doi: 10.1021/acsmedchemlett.7b00346. eCollection 2017 Oct 12.
5
Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy.使用新型蛋白酶-抗蛋白酶联合疗法加速糖尿病伤口愈合。
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15226-31. doi: 10.1073/pnas.1517847112. Epub 2015 Nov 23.
6
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.水溶性基质金属蛋白酶-9抑制剂可减少重度创伤性脑损伤后的损伤体积。
ACS Chem Neurosci. 2015 Oct 21;6(10):1658-64. doi: 10.1021/acschemneuro.5b00140. Epub 2015 Aug 14.
7
Water-soluble mmp-9 inhibitor prodrug generates active metabolites that cross the blood-brain barrier.水溶性 MMP-9 抑制剂前药可生成可穿透血脑屏障的活性代谢物。
ACS Chem Neurosci. 2013 Aug 21;4(8):1168-73. doi: 10.1021/cn400077d. Epub 2013 May 30.
8
Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations.将 CHARMM 通用力场扩展到含磺酰基的化合物及其在生物分子模拟中的应用。
J Comput Chem. 2012 Dec 5;33(31):2451-68. doi: 10.1002/jcc.23067. Epub 2012 Jul 23.
9
Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors.基于硫杂环丙烷的明胶酶抑制剂的构效关系
ACS Med Chem Lett. 2012 Jun 14;3(6):490-495. doi: 10.1021/ml300050b. Epub 2012 May 2.
10
Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe.利用三螺旋肽光学探针在体检测 MMP-2 和 MMP-9 的活性。
Bioconjug Chem. 2012 Mar 21;23(3):656-63. doi: 10.1021/bc300027y. Epub 2012 Feb 29.

本文引用的文献

1
Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.基质金属蛋白酶抑制剂:设计原则的批判性评价及提出的治疗用途。
Drugs. 2010 May 28;70(8):949-64. doi: 10.2165/11318390-000000000-00000.
2
Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.基质金属蛋白酶2(MMP2)抑制作用:SB - 3CT亚砜类似物去质子化引发的开环反应的密度泛函理论(DFT)和量子力学/分子力学(QM/MM)研究
J Phys Chem B. 2010 Jan 21;114(2):1030-7. doi: 10.1021/jp909327y.
3
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.硫杂环戊烷部分的活性部位开环和明胶酶的皮摩尔抑制作用。
Chem Biol Drug Des. 2009 Dec;74(6):527-34. doi: 10.1111/j.1747-0285.2009.00881.x. Epub 2009 Oct 6.
4
Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.基质金属蛋白酶2抑制作用:(4-苯氧基苯磺酰基)甲基硫杂环丙烷及其环氧乙烷类似物抑制机制的量子力学与分子力学联合研究
Biochemistry. 2009 Oct 20;48(41):9839-47. doi: 10.1021/bi901118r.
5
To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition.结合锌还是不结合锌:对改进金属蛋白酶抑制作用的创新方法的研究。
Biochim Biophys Acta. 2010 Jan;1803(1):72-94. doi: 10.1016/j.bbamcr.2009.08.006. Epub 2009 Aug 25.
6
Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.基质金属蛋白酶:小鼠模型中的进化、基因调控及功能分析
Biochim Biophys Acta. 2010 Jan;1803(1):3-19. doi: 10.1016/j.bbamcr.2009.07.004. Epub 2009 Jul 23.
7
DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.基质金属蛋白酶2强效抑制剂SB - 3CT开环机制的密度泛函理论研究
Org Lett. 2009 Jun 18;11(12):2559-62. doi: 10.1021/ol9008393.
8
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition.一种具有抗肿瘤侵袭活性的强效明胶酶抑制剂及其代谢情况。
Chem Biol Drug Des. 2009 Feb;73(2):189-202. doi: 10.1111/j.1747-0285.2008.00750.x.
9
Progress in the development of matrix metalloproteinase inhibitors.基质金属蛋白酶抑制剂的研发进展。
Curr Med Chem. 2008;15(14):1388-95. doi: 10.2174/092986708784567680.
10
Metabolism of a highly selective gelatinase inhibitor generates active metabolite.一种高选择性明胶酶抑制剂的代谢产生活性代谢物。
Chem Biol Drug Des. 2007 Nov;70(5):371-82. doi: 10.1111/j.1747-0285.2007.00577.x. Epub 2007 Oct 10.